<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-07-12)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-07-12)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>Biomanufacturing Industry to Face a ”Talent Singularity” in 2028</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-11</em></p>
<p>Talent is the impact an employee starts to have on an organization once the employee has achieved mastery. Their mixture of unique skills and experiences can be shown to affect business performance. The post Biomanufacturing Industry to Face a ”Talent Singularity” in 2028 appeared first on GEN - ...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/biomanufacturing-industry-to-face-a-talent-singularity-in-2028/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Why We Still Need Animal Research in a World of AI and Organoids</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-11</em></p>
<p>Critical funding for research on animals must continue today, but with a forward look to incorporating some emerging non-animal technologies that can, in tandem, help move biomedical science forward. The post Why We Still Need Animal Research in a World of AI and Organoids appeared first on GEN -...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/why-we-still-need-animal-research-in-a-world-of-ai-and-organoids/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Merck Acquires Verona, Virtual Cell Challenge, Gene Therapy Restores Hearing</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-11</em></p>
<p>In this episode of GEN's Touching Base, Merck acquires Verona Pharma for $10 billion. Additionally, Arc Institute launches an open benchmarking competition to evaluate virtual cell models while AAV-OTOF gene therapy shows promise in restoring hearing loss. The post Merck Acquires Verona, Virtual ...</p>
<p><a href='https://www.genengnews.com/topics/genome-editing/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Ofichem Acquires Avivia to Expand Formulation Development Capabilities</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-11</em></p>
<p>The acquisition further supports Ofichem’s ambition to evolve as a science-led contract development and manufacturing organization and deliver innovation-driven solutions to customers with enhanced capability in solving complex formulation challenges. The post Ofichem Acquires Avivia to Expand Fo...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/ofichem-acquires-avivia-to-expand-formulation-development-capabilities/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Wacker Chemie Opens Its Wacker Biotechnology Center in Munich</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-11</em></p>
<p>A key focus of the new biotechnology center will be on processes for the production of proteins and nucleic acids, which play an important role in developing innovative therapies. The post Wacker Chemie Opens Its Wacker Biotechnology Center in Munich appeared first on GEN - Genetic Engineering an...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/wacker-chemie-opens-its-wacker-biotechnology-center-in-munich/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry?</h3>
<p class='source-date'><em>Labiotech.eu • 2025-07-11</em></p>
<p>Turnstone Biologics is being acquired by royalty aggregator Xoma Royalty. Discover how royalty deals are shaping the biopharma industry. The post XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? appeared first on Labiotech.eu. © Labiotech UG a...</p>
<p><a href='https://www.labiotech.eu/trends-news/xoma-royalty-acquires-turnstone-biologics-royalty-deals-biopharma/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<div class='news-item'>
<h3>Anaerobic oxidation of short-chain volatile alkanes</h3>
<p class='source-date'><em>Trends in Microbiology • 2025-07-10</em></p>
<p>The short-chain volatile alkanes ethane, propane, and butane are major components of natural gas. Released from deep-seated subsurface reservoirs through natural seepage or gas extraction, they percolate through anoxic and oxic environments before reaching the atmosphere, where they contribute to...</p>
<p><a href='https://www.cell.com/trends/microbiology/fulltext/S0966-842X(25)00189-1?rss=yes' target='_blank'>Read more</a></p>
</div>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Combating Antimicrobial Resistance: Role of Key Stakeholders with Focus on the Pharmaceutical Sector.</h4>
<p class='source-date'><em>Sharma Sangeeta, Satyaseela Maneesh Paul, Burri Ranga Reddy et al. | Pharmaceutical medicine • 2025-07-11</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance is a pressing global health threat fueled by a complex interplay of biological, social, and economic factors. Despite widespread recognition of its impact, the antimicrobial resistance crisis continues to deepen because of inadequate innovation, poor access to effective t...</p>
<p><a href='https://doi.org/10.1007/s40290-025-00572-z' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Physically Enhanced Antibacterial Performance in Nanostructures Inspired by Nature: A Route to Avoiding Antimicrobial Resistance.</h4>
<p class='source-date'><em>Dou Haixu, Yi Yaozhen, Fu Xue et al. | Nano letters • 2025-07-11</em></p>
<p><strong>Abstract:</strong> The rise of antimicrobial resistance (AMR) and the challenge of developing safe and effective antibacterial strategies pose growing public health threats. Bioinspired nanostructured surfaces with mechano-bactericidal activity provide a purely physical antibacterial strategy without the risk of in...</p>
<p><a href='https://doi.org/10.1021/acs.nanolett.5c02325' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>KPC-157 and KPC-181 carbapenemases produced by Citrobacter freundii ST522 and Klebsiella pneumoniae ST258 isolated from wastewater.</h4>
<p class='source-date'><em>Furlan João Pedro Rueda, Bueno Giovanna Carrasco, Sousa-Carmo Rubens Renato et al. | Molecular biology reports • 2025-07-11</em></p>
<p><strong>Abstract:</strong> BACKGROUND: While novel KPC variants continue to emerge among clinically relevant Enterobacterales from hospital settings, their occurrence in impacted aquatic environments has been poorly investigated. We hereby report KPC-157 and KPC-181, allelic variants of KPC-2, produced by Citrobacter freun...</p>
<p><a href='https://doi.org/10.1007/s11033-025-10801-y' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Climate Change and the Microbial Shift: Unveiling Hidden Risks for Cancer Progression.</h4>
<p class='source-date'><em>Goplakrishnan Vinoj, Saravanan Vaijayanthi, Mahendran Maria Infant Majula Shifani et al. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2025-07-11</em></p>
<p><strong>Abstract:</strong> Climate change can lead to constant dysbiosis of the human microbiota, disrupting the delicate balance essential for maintaining good health. Climate change and its associated health risks are a growing area of research, yet its impact on human health, particularly for cancer patients and their r...</p>
<p><a href='https://doi.org/10.1158/1055-9965.EPI-25-0565' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Antibiotic susceptibility patterns of </h4>
<p class='source-date'><em>Aga Abebe M, Mulugeta Demise, Muleta Dassalegn et al. | Microbiology spectrum • 2025-07-11</em></p>
<p><strong>Abstract:</strong> UNLABELLED: The increasing prevalence of antimicrobial resistance in  IMPORTANCE: Antibiotic-resistant</p>
<p><a href='https://doi.org/10.1128/spectrum.00970-25' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<p>No recent papers on Synthetic & Molecular Biology available today.</p>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>Wearing bacteriophages individually with an adhesive drug-loadable nanohelmet for treating ocular infections.</h4>
<p class='source-date'><em>Meng Lu, Yang Fengmin, Cao Zhenping et al. | Science advances • 2025-07-11</em></p>
<p><strong>Abstract:</strong> Ocular infections pose notable blindness risks. Despite its advantages in inhibiting multidrug-resistant bacteria and eliminating biofilms, phage therapy suffers low phage vitality, limited ocular retention, and lack of anti-inflammatory abilities toward ocular infections. Here, wearing phages in...</p>
<p><a href='https://doi.org/10.1126/sciadv.adx4183' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Adaptive trade-offs between bacteriophage and antibiotic resistance in Salmonella Typhimurium.</h4>
<p class='source-date'><em>Zhang Song, Ahn Juhee | Microbial pathogenesis • 2025-07-08</em></p>
<p><strong>Abstract:</strong> This study was designed to evaluate the phenotypic properties of PBST35-resistant Salmonella enterica subsp. enterica serovar Typhimurium in association with adaptive trade-offs between bacteriophage resistance and antibiotic resistance. Bacteriophage-insensitive S. enterica Typhimurium (BIST) va...</p>
<p><a href='https://doi.org/10.1016/j.micpath.2025.107886' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>A bacterial host factor confines phage localization for excluding the infected compartment through cell division.</h4>
<p class='source-date'><em>Fiyaksel Osher Pollak, Dalvi Somavally Pundalik, Zhou Bing et al. | Cell reports • 2025-07-09</em></p>
<p><strong>Abstract:</strong> Viruses frequently induce the formation of specialized subcellular compartments to facilitate their replication and assembly. Here, we describe a "host-derived" confinement mechanism, compartmentalizing bacteriophage (phage) production to enable phage caging through cell division. By employing th...</p>
<p><a href='https://doi.org/10.1016/j.celrep.2025.115994' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan.</h4>
<p class='source-date'><em>Hayakawa Kayoko, Kiga Kotaro, Ojima Shinjiro et al. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy • 2025-07-08</em></p>
<p><strong>Abstract:</strong> INTRODUCTION: Personalized phage therapy is used in Europe and the United States to treat intractable infections caused by drug-resistant bacteria. This pilot study aimed to acquire feasibility data for clinical trials of individualized phage therapy in Japan. METHODS: An observational study was ...</p>
<p><a href='https://doi.org/10.1016/j.jiac.2025.102770' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Development of a novel CD3ε-specific human antibody for selective modulation of T cell activation.</h4>
<p class='source-date'><em>Yang Ha Rim, Kim Ji Woong, Choi Hye Lim et al. | International journal of biological macromolecules • 2025-07-08</em></p>
<p><strong>Abstract:</strong> CD3ε is an essential subunit of the T-cell receptor complex. It is required for T cell activation and immune modulation. Dysregulated CD3ε signaling results in abnormal T cell activation, contributing to the pathogenesis of various immune-related disorders, including autoimmune diseases. Although...</p>
<p><a href='https://doi.org/10.1016/j.ijbiomac.2025.145859' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<p>No recent papers on Skin Microbiome & Disease available today.</p>
<hr>
<p><em>Report generated on 2025-07-12</em></p>
</div>
</body>
</html>